The framework is set by worldwide initiatives by industries and governments: for example more than 500 investors request global listed businesses to statement their CO2 relevant business data through the Carbon Disclosure Task from the united kingdom. Global initiatives for Green Chemistry such as the conventions from Stockholm, Rotterdam and Basel, the OECD and the regulatory authorities of developed countries are working to create global standards for sustainable risk and chemical substances management. With the focus on ‘Green in IT’, specialists will discuss latest advancements of Green IT systems on the basis of recent successful projects to make processes more efficient, save assets and energy and reduce costs. These include concepts for IT virtualization in controlling chemical substance production or cloud processing for pharmaceutical research.Related StoriesNew antenna-like gadget makes breast cancer surgery easier for surgeonsStudy shows uncommon HER2 missense mutations do not spread breast cancer on their ownCrucial change in single DNA base predisposes children to aggressive form of cancer’We are pleased to have finished enrollment in our Phase I trial with ALN-VSP,’ said Jared Gollob, M.D., Senior Director, Clinical Study at Alnylam. ‘The info from this program have been encouraging to day, and the results are important not only for the continuing advancement of ALN-VSP toward Stage II studies but also for the overall advancement of systemically delivered RNAi therapeutics. We are presenting updated data out of this Phase I trial at the ASCO Annual Meeting in June.’ ‘Both primary liver malignancy and metastatic disease of the liver are associated with poor prognosis for individuals, and brand-new therapies are obviously needed,’ stated Josep Tabernero, M.D., Chairman of the Medical Oncology Phase and Department I System at Vall d’Hebron University Hospital in Barcelona, Spain.